Login / Signup

Synthesis of structural analogues of Reversan by ester aminolysis: an access to pyrazolo[1,5- a ]pyrimidines from chalcones.

Andres Arias-GómezMario A MacíasJaime Portilla
Published in: RSC advances (2023)
Reversan, a multidrug resistance-associated protein (MRP1) inhibitor described more than a decade ago, is a commercial drug (CAS: 313397-13-6) that has a high price and is six to eight times more potent than known drug transporter inhibitors. However, to date, a complete route for synthesizing pyrazolo[1,5- a ]pyrimidine-based Reversan is yet to be published. Herein, the silica gel-mediated synthesis of Reversan and a novel family of its structural analogues (amides) via the microwave-assisted amidation reaction of 3-carboethoxy-5,7-diphenylpyrazolo[1,5- a ]pyrimidine (ester) with primary amines is reported. Moreover, a set of this ester-type precursor was obtained using the NaF/alumina-mediated reaction of 5-amino-3-carboethoxy-1 H -pyrazole with chalcones, implying a final removal of H 2 using Na 2 S 2 O 8 . Both esters and amides were obtained in high yields using heterogeneous catalyst and solvent-free, highly efficient, and scalable synthetic protocols.
Keyphrases
  • highly efficient
  • molecular docking
  • ionic liquid
  • crispr cas
  • genome editing
  • pet ct
  • randomized controlled trial
  • drug induced
  • systematic review
  • electron transfer
  • metal organic framework
  • wound healing